Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NICE and new: appraising innovation.

× No keyword cloud information.

12 in total

1. Defining rewardable innovation in drug therapy.

Authors: Jeffrey K Aronson; Robin E Ferner; Dyfrig A Hughes
Journal: Nat Rev Drug Discov Date: 2012-03-30 Impact factor: 84.694

2. Reimbursement decisions of the All Wales Medicines Strategy Group: influence of policy and clinical and economic factors.

Authors: Warren G Linley; Dyfrig A Hughes
Journal: Pharmacoeconomics Date: 2012-09-01 Impact factor: 4.981

3. Do the EMA accelerated assessment procedure and the FDA priority review ensure a therapeutic added value? 2006-2015: a cohort study.

Authors: Denis Boucaud-Maitre; Jean-Jacques Altman
Journal: Eur J Clin Pharmacol Date: 2016-07-29 Impact factor: 2.953

4. Atti del 52° Congresso Nazionale: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI).

Authors:
Journal: J Prev Med Hyg Date: 2019-10-15

5. Patterns and predictors of physician adoption of new cardiovascular drugs.

Authors: Timothy S Anderson; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Rouxin Zhang; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Seth Richards-Shubik; Hasan Guclu; Bobby Jones; Julie M Donohue
Journal: Healthc (Amst) Date: 2017-10-21

Review 6. The role of bortezomib, thalidomide and lenalidomide in the management of multiple myeloma: an overview of clinical and economic information.

Authors: Andrea Messori; Dario Maratea; Chiara Nozzoli; Alberto Bosi
Journal: Pharmacoeconomics Date: 2011-04 Impact factor: 4.981

7. Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?

Authors: Adrian Towse
Journal: Br J Clin Pharmacol Date: 2010-09 Impact factor: 4.335

8. Value-based pricing: incentive for innovation or zero net benefit?

Authors: Dyfrig A Hughes
Journal: Pharmacoeconomics Date: 2011-09 Impact factor: 4.981

9. Pharmacoeconomics.

Authors: Dyfrig A Hughes
Journal: Br J Clin Pharmacol Date: 2012-06 Impact factor: 4.335

10. Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study.

Authors: Robert J Campbell; Sudeep S Gill; Susan E Bronskill; J Michael Paterson; Marlo Whitehead; Chaim M Bell
Journal: BMJ Date: 2012-07-04